When Streptomyces sp. strain Wak. A-305 is cultured in iron(III)-or cobalt(II)-containing media, tris(p-vinylphenyl-4-hydroxy-3-nitrosobenzoato-N3,04)ferrate(II) (ferroverdin) or the analogous tris-cobalt(III) complex, respectively, is produced intracellularly. In contrast, when cultured in transition metal ionlimiting media, Streptomyces sp. strain Wak. A-305 did not produce p-vinylphenyl 4-hydroxy-3-nitrosobenzoate (deferroferroverdin). Instead, deferriferrioxamines B and E, which have been characterized from other streptomycetes, were isolated extracellularly and may act as siderophores in this organism.
o-Nitrosophenolic compounds are classical reagents for the analytical determination of iron(II) and cobalt(III) (22) . This structural moiety is present in a number of natural products. Streptomyces viridans 1671 (14) and other Streptomyces species (8, 11) produce the extracellular antibiotics 4-hydroxy-3-nitrosobenzaldehyde (deferroviridomycin A) and its iron(II) complex. tris(4 -hydroxy -3 -nitrosobenzaldehydato -N3, 04)ferrate(II) (viridomycin A) in transition metal ion-limiting and iron(III)-containing media, respectively. The mode of antibiotic action of deferroviridomycin A against Escherichia coli appears to be membrane disruption (C.-C. Yang and J. Leong, submitted for publication). When cultured in media containing iron(III) or cobalt (II), Streptomyces sp. strain Wak. A-305 cells become green or red-brown, respectively (3, 4) . The color is due in part to tris(p-vinylphenyl-4 -hydroxy-3 -nitrosobenzoato-N3,04)-ferrate(II) (ferroverdin) or the analogous tris cobalt(III) complex. The X-ray structure of ferroverdin has been previously reported (9) . Although the biological function of these two complexes is obscure, ferroverdin displays no known antibiotic activity (4) .
Since these metal complexes may reflect which transition metal ions are present in the culture medium, we focused our attention on the biological function of the free ligand, p-vinylphenyl 4-hydroxy-3-nitrosobenzoate (deferroferroverdin). We report here that when Streptomyces sp. strain Wak. A-305 was cultured in iron-limiting media, deferroferroverdin was not produced, but two previously described siderophores (microbial iron transport agents [19] ), nocardamine (deferriferrioxamine E) (10) and deferriferrioxamine B (7), were produced extracellularly.
We first confirmed that Streptomyces sp. strain Wak. A-305 produced ferroverdin in two different culture media as described previously (3) . Ferroverdin production is known to be dependent upon the presence of iron in the culture medium (4) .
Streptomyces sp. strain Wak. A-305 was then grown at room temperature for approximately 10 days in chemically defined minimal medium (3), which was supplemented with 5 g of yeast extract (Difco Laboratories) per liter and from which FeCl3 * 6H20 and CoCl2 * 6H20 were omitted. The yeast extract was deferrated with 8-hydroxyquinoline as described previously (5) . Cell suspensions were removed every other day and filtered. After the colorless mycelium was washed once with fresh medium, it was extracted first with methanol and then with chloroform. When each of these organic extracts was shaken with a freshly prepared solution of ferrous ammonium sulfate in dilute sulfuric acid, no ferroverdin was obtained. Addition of ferrous ammonium sulfate to the original supematant fluids yielded an orange-red solution (see below). After this solution was extracted with ethyl acetate, thin-layer chromatography of the organic extracts was performed on silica gel 60F-254 thin-layer chromatography glass plates (EM Laboratories, Inc.) with 20% acetone-ethyl acetate (vol/vol) as the solvent system. Spots were detected visually. A control, which was supplemented with authentic ferroverdin but which did not contain cells, was subjected to the same procedure. Ferroverdin was not detected in any of the organic extracts. In summary, deferrofer-roverdin was not detected in either the mycelium or the culture supernatant fluids.
The iron-limiting, yeast extract-based medium described above was used for the production of extracellular iron(III)-reacting substances from strain A-305. After approximately 0.5 g of FeC13 * 6H20 was added per liter of culture supernatant fluids obtained by centrifugation of 10-day-old cultures, the orange-red suspension was saturated with ammonium sulfate, and the resulting slurry was extracted with benzyl alcohol and further treated by a previously described procedure (18) . The orange-red material was dissolved in 0.04 M sodium phosphate buffer, pH 3.5, and this solution was chromatographed at 4°C on a column containing carboxy methylSephadex C-25, sodium form, equilibrated in the same buffer. An orange-red band eluted with the buffer, whereas cationic orange-red material adhering to the column was eluted as a single band with a 0 to 1.5 M NaCl gradient in buffer. Both fractions were saturated with ammonium sulfate, and the resulting slurries were extracted with benzyl alcohol and further treated as described previously (18) . The orange-red solid from each fraction was dissolved in 0.2 M pyridine-acetic acid buffer, pH 7.4, and these solutions were chromatographed at 4°C on a Bio-Gel P-2 column (200 to 400 mesh, Bio-Rad Laboratories), equilibrated in the same buffer. Both ferric complexes were stored at 4°C. About equal quantities of each complex were obtained.
The iron-free ligands were obtained by treatment of the ferric complexes with 8-hydroxyquinoline as described previously (13) . For the noncationic ferric complex, the resulting aqueous phase was extracted with benzene instead of chloroform. Both ligands were further purified by chromatography at 4°C on a Bio-Gel P-2 column, equilibrated with 0.2 M pyridine-acetic acid buffer, pH 5.5. Both ligands were stored at 4°C. For spectroscopic measurements, the free ligand obtained from the cationic ferric complex was converted to the chloride salt by passage through a short DEAE-Sephadex A-25 column, chloride form, equilibrated in water.
The cationic ferric complex and its free ligand had identical behaviors observed by thin-layer chromatophy (6) and high-voltage paper electrophoresis as authentic ferrioxamine B and deferriferrioxamine B, respectively, whereas the other ferric complex and its ligand behaved identically to authentic ferrioxamine E and deferriferrioxamine E, respectively, both of which are electrically neutral. The neutral and cationic ferric complexes had extinction coefficients expected for ferrioxamine E (6) and ferrioxamine B (6), respectively. Equivalent weights of both free ligands obtained from spectrophotometric titrations with ferrous ammonium sulfate solu- tion agreed with molecular weights reported for deferriferrioxamine B (7) and deferriferrioxamine E (10). Furthermore, the cationic free ligand had 360-MHz proton nuclear magnetic resonance (NMR) spectra identical to those of authentic deferriferrioxamine B hydrochloride in d6-dimethyl sulfoxide (DMSO)-D20 ( Fig. 1 ) and d6-DMSO solutions (data not shown), whereas the neutral free ligand had spectra identical to those of authentic deferriferrioxamine E in the same solutions (Fig. 2) . The NMR resonances of the cationic and neutral free igands in the d6-DMSO-D20 solution were assigned by comparison with spectra of known compounds, including schizokinen (17) (23) , and a number of other species of Streptomyces (6, 23), whereas deferriferrioxamine E is also produced by species of Nocardia (21, 23) , Chromobacterium (16), Pseudomonas (15) , and several other Streptomyces species (6, 23) . A variety of microorganisms which do not produce these ligands are still able to use them as siderophores (12, 20, 24) . Finally, Desferal, the methanesulfonate salt of deferriferrioxamine B, has been used with some success in the treatment of acute accidental iron poisoning and iron overload diseases (2).
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